somavaratan

DRUG5 trials

Sponsors

Versartis Inc.

Conditions

Adult Growth Hormone DeficiencyAdult Growth Hormone Deficiency (AGHD)Growth DisordersGrowth Hormone DeficiencyPediatric Growth Hormone Deficiency

Phase 2

Versartis Long-Term Safety Study of Somavaratan

TerminatedNCT02068521

Versartis Inc.Pediatric Growth Hormone Deficiency

Start: 2014-03-03End: 2017-11-17Updated: 2018-03-09

Versartis International Trial in Adults With Long-Acting Growth Hormone

CompletedNCT02526420

Versartis Inc.Adult Growth Hormone Deficiency

Start: 2015-07-31End: 2016-10-31Updated: 2022-07-26

Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in Adult Growth Hormone Deficiency (AGHD)

TerminatedNCT02719990

Versartis Inc.Adult Growth Hormone Deficiency (AGHD)

Start: 2016-02-11End: 2018-01-11Updated: 2023-04-13

Phase 3

Long-Acting Growth Hormone in Children Compared to Daily rhGH

CompletedNCT02339090

Versartis Inc.Growth Disorders

Start: 2015-08-26End: 2017-08-23Updated: 2022-12-30

A Long-Term Safety Study of Somavaratan in Japanese Children With Growth Hormone Deficiency

TerminatedNCT03145831

Versartis Inc.Growth Hormone Deficiency

Start: 2017-03-31End: 2017-11-30Updated: 2018-03-09